ClinicalTrials.gov record NCT01659749
Educational, Social Support, and Nutritional Interventions and Their Cumulative Effect on Pregnancy Outcomes and Quality of Life in Teen and Adult Women With Phenylketonuria
Educational, Social Support, and Nutritional Interventions and Their Cumulative Effect on Pregnancy Outcomes and Quality of Life in Teen and Adult Women With Phenylketonuria (PKU) or Maple Syrup Urine Disease (MSUD).
AI summaryWhat this study is about, in plain languageShow ▾Hide ▴
AI-written from the registry record, not the study's own wording. May contain errors or omissions. Check the registry text on this page and the original record ↗ before acting on it.
This study runs a week-long Metabolic Camp for females age 11 and older with PKU or MSUD that combines education, social support, and nutrition instruction. Participants give blood and complete three-day food records at the start and end of camp; additional research tests may be offered. The study also compares pregnancy outcomes in women with PKU who attended Camp to those who did not. Data are collected to evaluate knowledge, diet adherence, metabolic measures, and quality of life.
What it is studying. The study tests whether an educational and social-support program delivered in a week-long camp affects metabolic control (blood amino acids), dietary phenylalanine intake, knowledge of disease and diet management, quality of life, reproductive-choice issues, and pregnancy outcomes. Measurements include blood samples and three-day food records at baseline and at the end of camp; other optional research assessments may include broader biomarker and health evaluations.
What the researchers hope to learn. To implement and evaluate an education and support program for females with PKU and MSUD. To measure changes in knowledge, dietary management and compliance, plasma amino acid concentrations, quality of life, and reproductive-choice issues after Camp. To gather clinical and research data (including broader biomarker profiling) and compare pregnancy outcomes in women with PKU who attended Camp versus those who did not.
What this study is about
The study's own summary, as published on ClinicalTrials.gov. Underlined terms have a short explanation.
The purpose of this project is to study the effectiveness of teaching teens and young women with Phenylketonuria (PKU) or Maple Syrup Urine Disease (MSUD) about their disease and nutrition related issues in a camp environment. It will also look at pregnancy outcome results in women with PKU who attended Metabolic Camp and compare their results to other women with PKU who have not attended the Metabolic Camp.
Interventions being studied
Being studied in this trial does not mean the treatment or procedure is approved or available for this condition.
- Behavioral
- Metabolic camp
Eligibility
The criteria exactly as listed on ClinicalTrials.gov. Only the study team can say whether they apply to you.
Inclusion criteria
- Diagnosed with PKU or other aminoacidopathy, female, age 11 or older, able to provide informed consent
Exclusion criteria
- Those not fitting the inclusion criteria
- Inclusion Criteria for healthy controls
- Individuals eligible to participate in this study must meet all of the following criteria:
- Adult camp counselors or staff determined to be in good health.
- Not diagnosed with PKU, MSUD or other hereditary metabolic disorder
- Willing and able to provide written informed consent
- Willing and able to comply with relevant camp guidelines and study procedures
Study description and what participation involves
The study's detailed description, as published on ClinicalTrials.gov.
Show the detailed description from the registry
Metabolic Camp is an educational and social support program with research opportunities that was developed in 1995 by Rani H. Singh, PhD, RD for females age 11 through adult with phenylketonuria (PKU) and maple syrup urine disease (MSUD), two inherited metabolic disorders (IMD). Camp provides a supportive environment for adolescent girls and women to learn about the importance of nutrition and diet self-management, with the intention of arresting the disease process and minimizing the instances of miscarriages and severe birth defects, which are high in this population. After 20+ years, Metabolic Camp is established as a unique, national program allowing up to 35 campers to live and learn during a week of nutritional support and productive activities, while simultaneously providing researchers an opportunity to gather important data. The aims of Metabolic Camp are 1) to implement education curriculum and support activities as an intervention program for females with PKU and MSUD, 2) to evaluate knowledge of disease and dietary management, dietary treatment compliance, quality of life, and reproductive choice issues and assess change in outcomes post-Camp, 3) to gather data through the implementation of a research protocol during baseline and post-Camp each year, and 4) to provide clinical and research training in IMD for professionals, from dietitians to medical students. Campers must complete an informed consent process, should they decide to participate in research activities. All campers submit a three-day food record and blood samples to measure plasma amino acids on the first and last day of camp, both of which are not classified as research activities, but rather standard of care for their disorder. Additional studies such as indirect calorimetry, bone health markers, anthropometric markers, nutritional status, mental and emotional wellbeing, neurocognitive functioning, access to disease specific care, metabolomic profiling, gut microbiota, and blood and urine analysis, have been and may continue to be assessed in those who participate in research pre and post-Camp. These are novel investigations for the study of IMD and essential to understand the physiological effects of Camp. In over 20 years of Metabolic Camp, the following data have been collected: health history and demographics, anthropometrics, dietary intake, compliance with medically prescribed diet, quality of life, physical activity, plasma amino acids, select blood and urine biomarkers, and bone density. Data are stored in REDCap, allowing evaluation of short- and long-term outcomes on the life course of females with PKU and MSUD. Each year, phenylalanine (Phe)/leucine (Leu) blood concentrations of campers decrease over the one week camp period, demonstrating better metabolic control and compliance with diet. Campers' knowledge of disease etiology, management, and effects, including Maternal PKU Syndrome (MPKU) are improved. Social support networks are strengthened by meeting peers with the same or similar disorder. The study protocol includes a comprehensive assessment of blood and urine biomarkers to examine PKU from a much broader approach compared to the traditional measurement of a single biomarker to assess patient status. Beneficial to campers and clinicians alike, Metabolic Camp is an invaluable experience to gain insight, knowledge, and stimulate new ideas related to research and optimal patient care.
AI summaryWhat participation may involve, in plain languageShow ▾Hide ▴
AI-written from the registry record, not the study's own wording. May contain errors or omissions. Check the registry text on this page and the original record ↗ before acting on it.
Participants stay for a week-long residential Metabolic Camp with education and social support activities. All campers complete a three-day food record and give blood samples for plasma amino acids on the first and last day (these two items are described as standard-of-care, not research). With separate informed consent, campers may also take part in additional research tests before and after camp such as urine samples, questionnaires about quality of life, body measurements, bone-health markers, indirect calorimetry, neurocognitive testing, metabolomic profiling, and gut microbiota analysis. Eligible adult counselors/staff who join as healthy controls would provide consent, be determined to be in good health, and may provide samples and complete questionnaires as described.
How the study is structured. An interventional, single-group (non-randomized), non-masked program where participants attend a week-long Metabolic Camp; researchers measure outcomes at the first and last day of camp and may collect additional research data before and after camp.
Questions you could ask
These questions are suggestions for a conversation with the study team or your own clinician, not advice.
- The listed sites are in United States. Is any of them reachable for me, and does the study help with travel?
- Which of the eligibility criteria would need to be checked with tests before I could join?
More on phenylketonuria
Important dates
- Study start
- June 1995
- Primary completion
- July 2035 (estimated)
- Study completion
- July 2037 (estimated)
- Target enrollment
- 200 participants (estimated)
- Last updated on registry
- May 7, 2026
- Data verified
- Oct 10, 2026
Sponsor and research team
The lead sponsor funds and oversees the trial. A pharmaceutical or biotech company sponsor typically means the study is testing that company's drug or device; a hospital, university, or government agency usually indicates investigator-initiated or publicly funded research.
- Lead sponsor
- Emory University
- Principal investigator
- Rani Singh, Professor
Emory University
Central study contact
If you're interested in participating, the central contact can answer general questions about the study — including eligibility requirements and how to find a recruiting site near you. Actual eligibility is determined by the site's medical team.
- Rani H Singh, PhD RD 📞 4047278519 ✉ rsingh@emory.edu
- Kristen Narlow, MS RD 📞 4047788610 ✉ kristen.narlow@emory.edu
Participating sites (1)
- Emory University Department of Human GeneticsRecruiting
Atlanta, Georgia, 30322 · United States
- Rani H Singh, PhD RD · 4047278519 · rsingh@emory.edu
Terms used on this page · explanations by MedicalUpdates.ai
- informed consent
- The process of explaining a study, including its risks and what participation involves, so that a person can decide freely whether to take part. Consent is usually documented in writing, and a participant can choose to leave the study later.
- inclusion criteria
- The conditions a person must meet to be considered for the study, for example a confirmed diagnosis, an age range or a test result.
- Exclusion Criteria
- The conditions that rule a person out even if they meet the inclusion criteria, for example other illnesses, certain medicines or pregnancy.
- baseline
- Measurements taken at the start of the study, before any study treatment, so that later results can be compared with them.
- standard of care
- Treatment generally considered appropriate for a condition in a particular clinical setting. It can vary by patient, place and over time. In many studies the new treatment is added to, or compared with, standard of care.
- biomarkers
- Something measurable in the body, such as a blood test result or an imaging finding, that indicates how a condition or treatment is behaving.
The study record on this page is reproduced from ClinicalTrials.gov, a database of the U.S. National Library of Medicine, where it was submitted by the study sponsor. MedicalUpdates.ai does not own this content, is not affiliated with or endorsed by ClinicalTrials.gov, NIH, or the U.S. Government, and does not verify the record. Plain-language notes, the glossary and the questions above are added by this site; text in the boxes marked "AI summary" was written by an AI model and may contain errors. Registry records change over time. Check the original record for the current version and discuss eligibility or participation with a qualified healthcare professional.
← Back to clinical trials